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We previously reported that mice deficient in acyl-
CoA-binding protein (ACBP) display a delayed meta-
bolic adaptation to weaning. This includes a delayed
activation of the hepatic lipogenic gene program,
which may result from hepatic accumulation of tria-
cylglycerol and/or cholesteryl esters in the late suck-
ling period. To further investigate the basis for this
phenotype, we generated mice deficient in ACBP in
hepatocytes (Alb-ACBP/) and keratinocytes (K14-
ACBP/). Surprisingly, the delayed adaptation to
weaning, including hepatic lipid accumulation, is
caused by ACBP deficiency in the skin rather than
in the liver. Similarly to ACBP/ mice, K14-ACBP/
mice exhibit an increased transepidermal water loss,
and we show that the hepatic phenotype is caused
specifically by the epidermal barrier defect, which
leads to increased lipolysis in white adipose tissue.
Our data demonstrate that an imperfect epidermal
barrier leads to profound suppression of the hepatic
SREBP gene program and lipid accumulation in the
liver.INTRODUCTION
The acyl-CoA-binding protein (ACBP) is a small intracellular pro-
tein that binds acyl-CoA esters in the range of C14–C22 with high
affinity and specificity (Rasmussen et al., 1990; Rosendal et al.,
1993; Faergeman et al., 1996). Based on in vitro investigations,
it is thought to act as an intracellular acyl-CoA pool former and
to transport acyl-CoA esters between different enzymatic sys-
tems within the cell (Faergeman et al., 2007; Chao et al., 2003;
Rasmussen et al., 1994; Faergeman and Knudsen, 1997). Tar-
geted disruption of ACBP (Acb1p) in Saccharomyces cerevisiae
indicates that ACBP is specifically involved in the synthesis of
complex lipids such as very-long-chain (C26) fatty acids (FAs),
ceramides, and sphingolipids (Gaigg et al., 2001; Faergeman
et al., 2004).Cell ReIn mammalian tissues, ACBP is ubiquitously expressed from
early embryogenesis to adulthood, but expression data (Neess
et al., 2006; Helledie et al., 2002; Sandberg et al., 2005) as well
as functional data (Bloksgaard et al., 2012; Langaa et al., 2012)
clearly indicate specialized functions in some cell types. We
recently generated mice with targeted disruption of the Acbp
gene (ACBP/). ACBP/ mice are viable, fertile, and born in a
normalMendelian ratio, demonstrating that ACBP is dispensable
for essential cellular functions (Neess et al., 2011). Interestingly,
however, the ability of ACBP/mice to surviveweaning is signif-
icantly decreased unless special care is taken, e.g., by supplying
soaked food and water in the bottom of the cage.
The weaning transition causes a dramatic dietary change from
lipid-rich breast milk to a chow diet rich in carbohydrates, and it
has been shown that concomitantly with this, a marked induction
of the hepatic lipogenic gene program occurs in rats (Botolin and
Jump, 2003; reviewed by Girard et al., 1992). Similarly, we
recently reported a marked induction of the lipogenic as well as
the cholesterogenic gene program inmouse liver during weaning
(Neess et al., 2011). Interestingly, ACBP/ mice display a de-
layed upregulation of these hepatic gene programs at weaning,
which is accompanied by a markedly lower hepatic de novo
cholesterol synthesis in ACBP/ mice at weaning. We showed
that the delayed induction of these gene programs could be ex-
plained by a markedly lower activity of sterol regulatory element
binding protein 1 (SREBP-1) and SREBP-2, the key regulators of
the lipogenic and cholesterogenic pathways in hepatocytes,
respectively. Furthermore, our data suggested that the suppres-
sion of SREBP activity was due to the transiently increased accu-
mulation of triacylglycerol (TAG) and cholesteryl esters (CEs) in
the liver of ACBP/ mice around the time of weaning.
Additionally, we recently reported that ACBP/mice display a
tousled fur with a greasy appearance and a reddish color. Impor-
tantly, we also demonstrated that these mice have an imperfect
epidermal barrier function, most likely caused by a significant
decrease in long- to very-long-chain (C20–28) free FAs (FFAs) spe-
cifically in thestratumcorneum (Bloksgaardet al., 2012). Thestra-
tum corneum is composed of protein-rich corneocytes
embedded in an extracellular lipidmatrix that contains ceramides
(50%), cholesterol (35%), and FFAs (15%). It serves as a perme-
ability barrier to prevent excessive evaporation of water from the
body as well as entry of pathogens and chemicals through theports 5, 1403–1412, December 12, 2013 ª2013 The Authors 1403
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Figure 1. The Liver Phenotype Is Not
Caused by an Endogenous Effect of ACBP
Depletion in the Liver
Mice with hepatocyte-specific deletion of ACBP
(Alb-ACBP/) were generated by mating ACBP-
floxmice carrying the loxP flanked Acbp allele with
mice expressing Cre recombinase under control of
the albumin promoter.
(A–C) The efficiency of the hepatic ACBP
knockout was investigated at the mRNA level by
real-time PCR (A) and at the protein level by
western blotting (B) and immunohistochemistry
(C). RNA expression data are shown as the
mean of three to ten individuals per group ±
SEM. For ACBP protein analysis by western
blotting, equal amounts of protein from three
individuals in each group were pooled and the
pooled samples were analyzed by western blot-
ting and enhanced chemiluminescence (ECL)
detection. ACBP immunohistochemistry in liver
sections is representative of three individuals in
each group.
(D) RNA was isolated from the livers of ACBP+/+ (n = 19), ACBP/ (n = 15), heterozygous control (n = 14), and Alb-ACBP/ (n = 7) mice at day 21, and
cDNA was processed and analyzed by real-time PCR on individual samples. Data are shown as mean ± SEM. Student’s t test was used to compare
ACBP/ with ACBP+/+, and Alb-ACBP/ with heterozygous controls (significance level p < 0.05). Numbers in gray indicate the fold change between the
two groups in case of significant difference.skin (reviewed by Proksch et al., 2008). Several genetic modifica-
tions that cause severe defects in the epidermal barrier function
have been shown to lead to neonatal lethality (Miyazaki et al.,
2005;Li et al., 2007;Cameronetal., 2007;Behneet al., 2000;Rad-
ner et al., 2010). The finding that the level of C26 FAs is specifically
reduced in the stratum corneum FFA pool but is unaffected in the
ceramide pool and in whole epidermis in ACBP/mice indicates
that overall FA chain elongation is not affected, but rather elonga-
tion, release, or trafficking of FFA to the stratum corneummay be
compromised by a lack of ACBP (Bloksgaard et al., 2012). Inter-
estingly, and in line with reports on mouse models with compro-
mised FA chain elongation in the skin (Westerberg et al., 2004;
Binczek et al., 2007), ACBP/mice display a significant increase
in transepidermal water loss (TEWL) (Bloksgaard et al., 2012).
Here, we further investigated the basis of the delayed hepatic
adaptation of ACBP/ mice to weaning. We report the genera-
tion of hepatocyte-specific (Alb-ACBP/) as well as keratino-
cyte-specific (K14-ACBP/) ACBP knockout strains, and
show that K14-ACBP/ mice are phenotypically similar to
mice with complete knockout of ACBP. Importantly, we demon-
strate that the delayed hepatic adaptation of ACBP/ mice to
weaning is not caused by ACBP depletion in the liver, but is spe-
cifically linked to the epidermal barrier dysfunction caused by
ACBP depletion in the keratinocytes. Our data indicate that the
impaired barrier function leads to increased lipolysis in the adi-
pose tissue and hepatic lipid accumulation, which suppresses
the hepatic lipogenic gene program.
RESULTS
The Delayed Hepatic Adaptation to Weaning in ACBP/
Mice Is Caused by a Systemic Effect
To further investigate the underlying cause of the delayed induc-
tion of hepatic lipogenic and cholesterogenic gene programs1404 Cell Reports 5, 1403–1412, December 12, 2013 ª2013 The Autduring weaning in ACBP/ pups (Neess et al., 2011; Figure 1D),
we generated mice with hepatocyte-specific deletion of ACBP
(Alb-ACBP/). This was done by mating ACBP-flox mice car-
rying the floxed Acbp allele with mice expressing the Cre recom-
binase under control of the albumin promoter (Figure S1). As
opposed to the conventional ACBP/ mice, Alb-ACBP/
mice develop normally and have a normal wild-type macro-
scopic appearance (data not shown). This shows that the skin
and fur phenotype (Bloksgaard et al., 2012) of ACBP/ mice
is caused by ACBP deficiency in tissues other than the liver.
Inorder toevaluate theefficiencyof thehepaticACBPknockout,
we analyzedAcbpmRNAexpression levels by real-timePCR, and
protein levels and distribution bywestern blotting and immunohis-
tochemistry, respectively. The results showed that the mRNA
expression of Acbp was almost completely abolished in Alb-
ACBP/ liver at day 21, when the hepatic phenotype of ACBP/
mice is significant (Figure 1A). It was previously reported that the
albuminpromoter is not fully activeduring thefirstweeksafter birth
(Postic and Magnuson, 2000). However, in the liver of Alb-
ACBP/ mice, Acbp mRNA expression was reduced to 7% of
that in heterozygous control liver as early as day 3, suggesting a
recombination efficiency of at least 93% (considering also the
contribution from nonhepatic cells). At 12, 21, 29, and 56 days of
age, the recombination efficiency, as determined by Acbp
mRNA expression in the liver, was at least 93%, 94%, 98%, and
99%, respectively (Figure 1A). At the protein level, ACBP was un-
detectable by western blotting at all ages examined (Figure 1B).
Furthermore, immunohistochemical detection demonstrated that
ACBPwasspecificallydepleted inhepatocytes fromAlb-ACBP/
liver at day 21 (Figure 1C). Taken together, these results show an
efficient knockout of ACBP in the liver from Alb-ACBP/ mice
at an early time point during the suckling period.
To evaluate whether Alb-ACBP/ mice display a liver pheno-
type similar to that of ACBP/ mice at weaning, we determinedhors
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Figure 2. Delayed Adaptation to Weaning in ACBP/ Mice Is Independent of the Mother’s Genotype
(A) The ACBP/ and ACBP+/+ mice used were bred in homozygous litters; however, at day 3 after birth, the mothers were swapped. Thus, ACBP/ pups were
nursed by ACBP+/+ mothers, and ACBP+/+ pups were nursed by ACBP/ mothers between days 3 and 21.
(B) At day 21, RNA was isolated from the livers of ACBP+/+ (n = 13) and ACBP/ (n = 14) mice cross-nursed by opposite mothers.
(C) RNA was isolated from the livers of ACBP+/+ (n = 9) and ACBP/ (n = 13) pups born in heterozygous crosses, i.e., ACBP/ and ACBP+/+ littermates born and
breastfed by heterozygous mothers. In (B) and (C), cDNA was prepared and analyzed by real-time PCR on individual samples. Data are shown as mean ± SEM.
Student’s t test was used to compare hepatic gene expression between ACBP+/+ and ACBP/ (significance level p < 0.05). Numbers in gray indicate fold change
between the two groups in case of significant difference.mRNA expression of lipogenic and cholesterogenic SREBP
target genes at day 21. Interestingly, mRNA expression of
the SREBP target genes acetyl-CoA synthetase (Acss2), FA
synthase (Fasn), 3-hydroxy-3-methylglutaryl-CoA reductase
(Hmgcr), squalene epoxidase (Sqle), and lanosterol synthase
(Lss) was similar between heterozygous control and Alb-
ACBP/ livers at day 21 (Figure 1D). Thus, unlike ACBP/
mice, Alb-ACBP/ mice do not show a delayed upregulation
of the SREBP gene program at weaning, indicating that the delay
is caused by systemic effects of ACBP depletion rather than by
ACBP depletion in the liver per se.
The Delayed Hepatic Adaptation to Weaning in ACBP/
Mice Is Independent of the Genotype of the Mother
During the suckling/weaning period, the pups consume breast
milk and an increasing amount of chow. Breast milk production
is highly dependent on lipid uptake, synthesis, and transport in
the mammary gland alveolar cells for the generation of TAG
and membrane lipids in the production of milk fat globules
(Neville and Picciano, 1997). Given that ACBP binds acyl-
CoA esters, we speculated that the amount and composition
of lipids in milk fat might be altered in lactating ACBP/
mice. The ACBP/ and ACBP+/+ mice used for the above-
mentioned studies were all bred in homozygous litters, i.e.,
ACBP/ mothers gave birth to ACBP/ pups and ACBP+/+
mothers gave birth to ACBP+/+ pups. In order to investigate
whether the genotype of the mother could be involved in the
development of the liver phenotype at weaning, we swappedCell Rethe ACBP/ and ACBP+/+ mothers at day 3 after birth.
Thus, ACBP/ pups were nursed by ACBP+/+ mothers and
ACBP+/+ pups were nursed by ACBP/ mothers between
days 3 and 21 (Figure 2A). Analysis of hepatic gene expression
at 21 days of age showed that mRNA expression of Acss2,
Fasn, Hmgcr, Sqle, and Lss was reduced in ACBP/ livers
compared with ACBP+/+ livers independently of whether the
pups were nursed by ACBP/ or ACBP+/+ mothers (Figure 2B).
This indicates that the changes in hepatic gene expression are
unrelated to behavioral differences or alterations in the compo-
sition or amount of breast milk in the ACBP/ mothers.
To further substantiate this finding, we analyzed hepatic gene
expression in pups born in heterozygous crosses, i.e., ACBP/
and ACBP+/+ littermates born and breastfed by heterozygous
mothers. The results showed that the decreased expression of
SREBP target genes at 21 days of age in the livers from ACBP/
pups compared with ACBP+/+ pups was similarly independent of
whether the pups were born by ACBP+/ or ACBP/ mothers
(Figure 2C). Taken together, these data show that the delayed
upregulation of the SREBPgene program at weaning in ACBP/
pups is caused primarily by the lack of ACBP in the pups and not
the mothers.
Skin-Specific Deletion of ACBP Leads to Suppression
of the Hepatic SREBP Gene Program
The skin/fur phenotype of ACBP/ mice (Bloksgaard et al.,
2012) becomes evident around day 16, i.e., around the same
time as the changes in hepatic lipid accumulation and SREBPports 5, 1403–1412, December 12, 2013 ª2013 The Authors 1405
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Figure 3. Keratinocyte-Specific Depletion of
ACBP Is Causal for the Hepatic Phenotype
at Weaning
Keratinocyte-specific deletion of ACBP (K14-
ACBP/) was performed by mating ACBP-flox
mice carrying the loxP flanked Acbp allele with mice
expressing Cre recombinase under control of the
K14 promoter.
(A) Keratinocyte-specific ACBP knockout efficiency
was analyzed at day 21 in isolated stomach skin by
real-time PCR on individual samples. Data are
shown as mean ± SEM.
(B) ACBP protein distribution was investigated on
the skin of the foot sole by immunohistochemistry
as described previously (Neess et al., 2011).
(C) TEWL values for ACBP+/+ (n = 8) and ACBP/
(n = 8) were reported previously (Bloksgaard et al.,
2012) and are shown for comparison.
(D) In this study, TEWL was determined in adult
heterozygous control (n = 7) and K14-ACBP/
(n = 6) male mice. Data are shown asmean values of
the individuals in each group ±SEM. Student’s t test
was used to compare TEWL values between
ACBP+/+ and ACBP/ mice, as well as between
heterozygous control and K14-ACBP/ mice.
Significance level p < 0.05.
(E) Hepatic mRNA expression of SREBP target
genes in 21-day-old K14-ACBP/ mice was
analyzed. RNA was isolated from the livers of
heterozygous control (n = 14) and K14-ACBP/
(n = 14) mice at day 21, and cDNA was prepared and analyzed by real-time PCR on individual samples. Data are shown as mean values of the individuals in each
group ± SEM. Student’s t test was used to compare hepatic gene expression between the livers of ACBP+/+ and ACBP/ mice. Significance level p < 0.05.
Numbers in gray indicate fold change between the two groups in case of significant difference.target gene expression arise (Neess et al., 2011). To investigate
whether the skin/fur phenotype of ACBP/ mice (Bloksgaard
et al., 2012) is causally involved in the delayed adaptation to
weaning, we generated mice with keratinocyte-specific deletion
of ACBP (K14-ACBP/). This was done by mating ACBP-flox
mice with mice expressing Cre recombinase under control of
the K14 promoter.
K14-ACBP/ mice display a skin/fur phenotype that is iden-
tical in macroscopic appearance and timing to that of ACBP/
mice, indicating that the macroscopic skin/fur phenotype of
ACBP/ mice is caused at least primarily by ACBP deficiency
in the keratinocytes. Analysis of Acbp mRNA expression in total
skin of K14-ACBP/mice revealed that at day 21,Acbpwas still
expressed at approximately 30% of the level found in heterozy-
gous control mice (Figure 3A). However, immunohistochemical
detection showed that ACBP protein was virtually absent from
the keratinocytes in epidermis (Figure 3B), indicating that the
K14-directed Cre-mediated recombination of the ACBP-flox
allele was efficient and keratinocyte specific. Thus, the relatively
high levels of AcbpmRNA in total skin samples are likely to result
fromAcbp expression in skin cells other than keratinocytes, such
as fibroblasts, macrophages, muscle and fat cells, and sebo-
cytes of the sebaceous glands.
We previously showed that concomitantly with the decrease in
very-long-chain FAs in the stratum corneum, the epidermal bar-
rier function is compromised in adult ACBP/ mice, as evi-
denced by a significant increase in TEWL (Bloksgaard et al.,
2012; Figure 3C). Similarly, K14-ACBP/ mice display a signif-1406 Cell Reports 5, 1403–1412, December 12, 2013 ª2013 The Auticantly elevated TEWL (Figure 3D), further supporting the notion
that the skin phenotype of these mice is caused primarily by loss
of ACBP in the keratinocytes.
Interestingly, when we compared hepatic gene expression
in K14-ACBP/ and heterozygous control littermates at
day 21, we observed that K14-ACBP/ mice exhibited a dra-
matic suppression of lipogenic and cholesterogenic gene
expression at weaning similar to that observed for ACBP/
mice (Figure 3E). This indicates that keratinocyte-specific
disruption of ACBP is the primary cause of the delayed hepatic
adaptation to weaning.
An Artificial Barrier on the Skin Rescues the Weaning
Liver Phenotype of ACBP/ Mice
The finding that the hepatic gene expression of K14-ACBP/
pups recapitulates the suppression of the SREBP gene pro-
grams observed in ACBP/ pups during weaning indicates
that the keratinocytes directly or indirectly signal to the hepato-
cytes. We considered the possibility that increased inflamma-
tory signals from the keratinocytes could be involved. However,
we failed to detect a good correlation between inflammatory
signals in the skin and the hepatic phenotype around weaning
(data not shown). This prompted us to investigate whether sup-
pression of the SREBP gene program could be caused by the
decrease in epidermal barrier function per se. Vaseline has
been shown to improve the defects of a compromised
epidermal barrier function by efficiently reducing TEWL (Stama-
tas et al., 2008; Ghadially et al., 1992; Binczek et al., 2007;hors
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Figure 4. An Artificial Barrier on the Skin Rescues Expression of the Hepatic SREBP Gene Program
(A and B) Vaseline was topically applied twice a day from age 7 days until age 21 days to the skin of the entire body of ACBP+/+ (n = 12) and ACBP/ (n = 12) mice
(A), and hepatic gene expression was determined on day 21 (B).
(C and D) Latex was applied topically at days 7 and 14 on ACBP+/+ (n = 9) and ACBP/ (n = 10) mice, in order to cover the mouse skin from day 7 to day 21 of age
(C), and SREBP target gene expression was investigated at day 21 (D). Real-time PCRwas performed on individual samples and data are shown asmean ± SEM.
Student’s t test was used to compare different genotypes within the same group (Vaseline or latex treated). Significance level p < 0.05. Numbers in gray indicate
fold change between the two groups in case of significant difference.Patzelt et al., 2012). Therefore, we applied Vaseline to the skin
of the entire body of ACBP/ and ACBP+/+ mice twice a day
from age 7 days to 21 days (Figure 4A), and determined hepatic
gene expression on day 21. Interestingly, the suppression of
SREBP target genes was almost completely rescued by Vase-
line treatment (Figure 4B). In the case of Acss2, there was
slightly lower mRNA expression in the liver of ACBP/ mice
compared with ACBP+/+ mice at day 21, whereas for the other
genes tested (Fasn, Hmgcr, Sqle, and Lss), there was no signif-
icant difference in mRNA expression between the livers of vase-
line-treated ACBP/ and ACBP+/+ mice at day 21.
It has been reported that topical administration of Vaseline on
the skin results in the absorption of this compound, in the form of
FAs, in the stratum corneum, the uppermost layer of epidermis
(Stamatas et al., 2008; Ghadially et al., 1992). Therefore, it is
possible that the effect of applying Vaseline to the skin of
ACBP/ mice could be caused not only by the occlusion of
the skin but also by the penetration of Vaseline and thus FAs
into the stratum corneum. Furthermore, when Vaseline is applied
to the surface of mice, there is a risk that the pups might ingest
FAs from the Vaseline during grooming. Therefore, we decided
to use latex as an alternativemeans ofmaking an artificial barrier.
Latex was applied topically to ACBP/ and ACBP+/+ mice (Fig-
ure 4C; Ahrens et al., 2011; S.B., unpublished data) at day 7 and
14, thereby ensuring that the skin was covered from day 7 to day
21. Similarly to Vaseline, latex treatment rescued hepatic SREBP
target gene expression (Figure 4D). Thus, taken together, these
results show that the compromised epidermal barrier function
per se in ACBP/ mice is the primary cause of the suppression
of the hepatic SREBP gene programs.Cell ReDisruption of ACBP in the Skin Causes CE Accumulation
in the Liver
Our previous results suggested that the transient accumulation
of CE and/or TAG in the liver of ACBP/ pups during the last
phase of suckling might be implicated in the suppression of
the hepatic SREBP gene program (Neess et al., 2011). We there-
fore investigated how hepatic CE and TAG levels correlated with
suppression of SREBP target gene expression in the other
mouse models described above. As shown previously (Neess
et al., 2011), there was a greater accumulation of CE in the liver
of 21-day-old ACBP/mice compared with ACBP+/+ mice (Fig-
ure 5A). Interestingly, the livers of 21-day-old Alb-ACBP/mice
showed CE levels similar to those of heterozygous control mice,
whereas the livers of 21-day-old K14-ACBP/ mice displayed
significantly greater hepatic CE accumulation compared with
control animals, although the difference was smaller than that
between ACBP/ and ACBP+/+ mice (Figure 5A). Importantly,
the hepatic CE accumulation in ACBP/mice could be reverted
by applying an artificial epidermal barrier on the skin by either
Vaseline or latex (Figure 5A). This indicates that the hepatic accu-
mulation of CE is coupled to ACBP deficiency in the skin and
more specifically to the disrupted epidermal barrier of ACBP/
and K14-ACBP/ mice at weaning.
In addition to the hepatic CE accumulation, we confirmed the
previously reported (Neess et al., 2011) accumulation of TAG in
the liver from 21-day-old ACBP/ mice compared with
ACBP+/+ mice (Figure 5B). As with the CE levels, the TAG levels
were comparable between Alb-ACBP/ mice and heterozy-
gous control mice (Figure 5B). The K14-ACBP/mice appeared
to have a slightly elevated level of hepatic TAG at day 21 whenports 5, 1403–1412, December 12, 2013 ª2013 The Authors 1407
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Causes CE Accumulation in the Liver
(A and B) CE (A) and TAG (B) levels were deter-
mined in the livers of 21-day-old ACBP/ (n = 8),
ACBP+/+ (n = 8), heterozygous control (n = 8), Alb-
ACBP/ (n = 5), and K14-ACBP/ (n = 8) mice.
Furthermore, CE and TAG levels were determined
after applying an artificial epidermal barrier on the
skin by either Vaseline (ACBP/ n = 5; ACBP+/+
n = 5) or latex (ACBP/ n = 5; ACBP+/+ n = 4). Total
lipids were extracted from individual tissue sam-
ples and equal amounts of lipid were pooled in
each group. Equal amounts of lipid extracts,
including standards, were sprayed onto TLC
plates. Quantification was performed using Im-
ageJ 1.45 software. Data are shown as mean ±
SEM. Student’s t test was used to compare CE
and TAG mean values between ACBP/ and
ACBP+/+ data (significance level p < 0.05). One-
way ANOVA was used to compare heterozygous
control mice with Alb-ACBP/ and K14-ACBP/
(significance level p < 0.05/2).compared with control animals. However, it was not as pro-
nounced as in the ACBP/ mice, and due to the large individ-
ual-to-individual variation, the difference was not statistically
significant (Figure 5B). Importantly, the TAG accumulation in
ACBP/ mice was abolished by topical application of Vaseline
or latex (Figure 5B), suggesting that the imperfect permeability
barrier of ACBP/ epidermis contributes significantly to the
elevated TAG levels in ACBP/ livers at weaning.
Taken together, these data support the notion that suppres-
sion of hepatic SREBP activity in ACBP/ mice at weaning is
coupled to the accumulation of CE and possibly TAG in the liver,
and that the defective epidermal barrier of ACBP/ mice con-
tributes significantly to this accumulation.
The Defect in Epidermal Barrier Function Leads to
Increased Lipolysis in the White Adipose Tissue of
ACBP/ Mice
As shown above, there is a clear connection between the
epidermal barrier defect and the accumulation of CE and TAG
in the liver of ACBP/ mice at weaning. Furthermore, we have
preliminary data indicating that ACBP-deficient mice have diffi-
culties maintaining their body temperature when removed from
their mother prior to the time of weaning. Based on these find-
ings, we hypothesize that the defective epidermal barrier might
lead to elevated heat loss across the skin and thus an overall
elevation of energy expenditure in ACBP/ mice, to allow
them to defend their body temperature. Thus, the defective
epidermal barrier is likely to mimic a cold-exposure response.
Notably, cold exposure also leads to increased storage of lipids
in the liver, most likely due to increased white adipose tissue
(WAT) lipolysis, and thereby elevated FA flux to the liver (D.N.,
A.B.M., S.B., unpublished data).
Indirect calorimetric experiments with the pups were
hampered for a number of reasons, including the weakness of
ACBP/ mice during the weaning period, their reduced ability
to maintain normal body temperature when housed individually,1408 Cell Reports 5, 1403–1412, December 12, 2013 ª2013 The Autand the fact that the pups were breastfeeding and therefore
could not be housed without their mother. However, we deter-
mined lipolysis in isolated WAT. Inguinal WAT from ACBP/
and ACBP+/+ mice was incubated in Krebs-Ringer buffer at
37C for 30 min. This revealed an increased release of glycerol
from WAT from ACBP/ compared with ACBP+/+ mice (Fig-
ure 6A), thus indicating that lipolysis is elevated in WAT from
ACBP/ mice at day 21. To further substantiate this finding,
we investigated the Ser563 phosphorylation state of the hor-
mone-sensitive lipase (HSL) in WAT, which is associated with
lipolysis (Lampidonis et al., 2011). We isolated inguinal WAT
from 21-day-old ACBP+/+, ACBP/, heterozygous control,
and K14-ACBP/ mice, as well as Vaseline-treated ACBP/
and ACBP+/+ mice, and determined the levels of Ser563 phos-
phorylated HSL (pHSL) and total HSL in each sample by western
blotting followed by ImageJ quantification (Figure S2). The re-
sults showed a significant increase in the relative level of pHSL
over total HSL inWAT isolated from ACBP/ and K14-ACBP/
mice compared with ACBP+/+ and heterozygous control mice,
respectively (Figure 6B). This strongly supports the notion that
WAT lipolysis is elevated upon Acbp disruption specifically in
the keratinocytes. Importantly, Vaseline treatment prevented
the increase in pHSL in ACBP/ relative to ACBP+/+ WAT (Fig-
ure 6B). In fact, we observed a reversal of the effect, with a
reduced pHSL/HSL in ACBP/ WAT compared with that of
ACBP+/+ mice. The reason for this remains unclear; however, it
is possible that compensatory mechanisms in the WAT of
ACBP/ mice could play a role.
Taken together, these data support the hypothesis that
depletion of ACBP in mice causes elevated water and heat
loss across the skin, which then leads to elevated energy ex-
penditure and increased lipolysis in WAT. Furthermore, and
importantly, these experiments demonstrate that this is caused
specifically by ACBP depletion in the keratinocytes and is
directly coupled to the defect in barrier function upon ACBP
depletion.hors
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Figure 6. Elevated Lipolysis and Phosphorylation of HSL in ACBP/
WAT
(A) The amount of glycerol released from WAT isolated from ACBP+/+ (n = 8)
and ACBP/ (n = 4) mice was determined to evaluate WAT lipolysis. Proteins
were extracted from inguinal WAT from 21-day-old ACBP+/+ (n = 5), ACBP/
(n = 6), heterozygous control (n = 5), and K14-ACBP/ (n = 6) mice, as well as
Vaseline-treated ACBP+/+ (n = 4) and ACBP/ (n = 5) mice, and analyzed by
western blotting followed by ECL detection.
(B) The amount of pHSL was normalized to total HSL (pHSL/HSL) for individual
samples (Figure S2). Data are shown as mean values of the individuals in each
group ± SEM. Student’s t test was used to compare lipolysis (A) and pHSL/
HSL ratios (B) between WAT samples. Significance level p < 0.05.DISCUSSION
We previously showed that targeted disruption of the Acbp gene
in mice causes a delayed hepatic adaptation to weaning, with a
delayed upregulation of the lipogenic and cholesterogenic path-
ways (Neess et al., 2011). Our results indicated that this was
caused by the transiently increased accumulation of TAG and
CE in the liver, which may suppress expression and/or process-
ing of the SREBP transcription factors. As ACBP is highly ex-
pressed in the liver (Neess et al., 2006), the most straightforward
explanation was that this delayed hepatic adaptation was
caused by lack of ACBP in hepatocytes. This was supported
by previous results showing that siRNA-mediated knockdown
of ACBP in HepG2 cells caused a 1.3- to 1.7-fold decrease in
lipogenic and cholesterogenic gene expression (Vock et al.,
2010). Surprisingly, however, in our current study, we found
that disruption of ACBP specifically in the hepatocytes (Alb-
ACBP/) did not cause delayed hepatic adaptation to weaning
or increased accumulation of hepatic TAG andCE. This indicates
that the suppression of hepatic SREBP target genes at weaning
is caused primarily by a systemic effect, rather than by lack of
ACBP in the liver. By using different breeding patterns and
swap of mothers, we found that this systemic effect was unre-
lated to the genotype of the mother. Thus, the systemic effect
originates in the pups and is not linked to, e.g., the composition
of the breast milk.Cell ReBecause the macroscopic skin/fur phenotype of ACBP/
mice becomes evident shortly before weaning, we generated
mice with keratinocyte-specific knockout of ACBP (K14-
ACBP/). These mice displayed a macroscopic phenotype as
well as increased TEWL similar to that observed in ACBP/
mice, indicating that the skin/fur phenotype of ACBP/ mice
is caused specifically by the absence of ACBP in the keratino-
cytes. Intriguingly, we also found that the delayed hepatic adap-
tation to weaning in ACBP/ mice is recapitulated in K14-
ACBP/ mice, indicating that lack of ACBP in the skin leads
to deregulation of hepatic FAs aswell as cholesterol metabolism.
Using either Vaseline or latex to generate an artificial barrier on
the skin of ACBP/mice, we showed that the coupling between
the liver phenotype at weaning and ACBP deficiency in the skin is
specifically caused by the disrupted epidermal barrier. It should
be emphasized, however, that although the defect in epidermal
barrier function persists in adult mice, it is only during the narrow
time window of weaning that this gives rise to changes in hepatic
gene expression. It is unclear why hepatic gene regulation is
particularly sensitive to the defect in the epidermal barrier around
weaning; however, it is possible that compensatory mechanisms
in the liver prohibit these effects later in life.
The link between the epidermal barrier function and hepatic
lipogenesis and cholesterogenesis has not previously been
demonstrated. However, based on our finding in ACBP/
mice that disruption of the epidermal barrier leads to delayed up-
regulation of the hepatic SREBP-1 and SREBP-2 activities dur-
ing weaning, we would predict similar effects on hepatic gene
expression during weaning in other mouse models with a defec-
tive epidermal barrier. Constitutive as well as skin-specific abla-
tion of ELOVL3 (Westerberg et al., 2004) and SCD1 (Miyazaki
et al., 2001; Sundberg et al., 2000; Sampath et al., 2009) in
mice leads to macroscopic skin and fur phenotypes similar to
those of ACBP/ and K14-ACBP/ mice, including sparse
hair with a matted/tousled appearance of the fur and increased
TEWL. Our results suggest that these mouse models might
display a similar delayed induction of the hepatic SREBP-driven
lipogenic and cholesterogenic gene programs during weaning. It
was previously reported that the lower level of SREBP-1 in adult
SCD1/mice (Miyazaki et al., 2004) is primarily caused by a lack
of SCD1 in the liver (Miyazaki et al., 2007), and not by a lack of
SCD1 in the skin (Sampath et al., 2009). Notably, however, these
studies were carried out in adult mice and reported no effect on
SREBP-2 activity. The fact that skin-specific ablation of SCD1
does not lead to major suppression of the SREBP-1 and
SREBP-2 gene programs in adult mice despite the imperfect
epidermal barrier is consistent with our observation that these
hepatic gene programs are particularly sensitive to the epidermal
barrier defect during weaning.
The mechanism that leads to suppression of SREBP-1 and
SREBP-2 activities in the liver of ACBP/ mice during weaning
is not entirely clear. We previously hypothesized that accumula-
tion of CE and TAG in the liver of ACBP/mice was the cause of
delayed SREBP activation (Neess et al., 2011), and the results
presented here support this notion. Thus, mouse models with
an imperfect epidermal barrier (ACBP/ and K14-ACBP/)
display increased hepatic levels of CE, and in some cases
(ACBP/) also TAG, as well as a parallel suppression of SREBPports 5, 1403–1412, December 12, 2013 ª2013 The Authors 1409
target genes. By contrast, mouse models with a normal
epidermal barrier (ACBP+/+, Alb-ACBP/, and Vaseline- or
latex-covered ACBP/mice) all display normal levels of hepatic
CE and TAG, and normal expression of SREBP target genes in
the liver. Consistent with the notion that increased hepatic levels
of CE and TAG can lead to suppression of SREBP target genes, it
was previously reported that high-fat feeding of HSL/ mice
leads to increased hepatic levels of CE accompanied by reduced
expression of genes in the cholesterogenic pathway (Fernandez
et al., 2008). The mechanistic details of how an increased flux of
FFAs to the liver leads to suppression of SREBP activity are not
clear. We consider it most likely that a mass action of FAs is the
cause; however, it is also possible that specific FAs are themajor
players.
An intriguing question is, how does disruption of the epidermal
barrier lead to an increase in hepatic CE and TAG? We propose
that the increased TEWL leads to increased heat loss across the
skin, which might stimulate lipolysis in the adipose tissues. This
in turn may result in an increased flux of FFAs to the liver, as well
as accumulation of hepatic CE and TAG. Consistent with this hy-
pothesis, we report an elevated lipolysis in WAT isolated from
21-day-old ACBP/ mice and a concomitant increase in phos-
phorylation of HSL in WAT isolated from 21-day-old ACBP/
and K14-ACBP/ mice compared with ACBP+/+ and heterozy-
gous control mice, respectively. Furthermore, we demonstrate
that the increased phosphorylation of HSL is reversed by regen-
erating the skin barrier by topical application of Vaseline.
Together, these results provide important evidence of the link
between the epidermal barrier defect and the increase in WAT
lipolysis.
In summary, we demonstrate here that hepatic gene expres-
sion during weaning is very sensitive to the function of the
epidermal barrier. Specifically, we have shown that ablation of
ACBP in the epidermis leads to compromised epidermal barrier
function, which results in elevated WAT lipolysis, hepatic lipid
accumulation, and delayed induction of the SREBP gene pro-
grams in mouse liver during weaning. Future investigations are
needed to fully clarify the molecular mechanisms by which the
defect in epidermal barrier function and the increased lipolysis
in WAT affect hepatic adaptation to weaning.EXPERIMENTAL PROCEDURES
Generation and Housing of Mice
Mice with constitutive targeting of the Acbp gene have been described pre-
viously (Neess et al., 2011). Conditional targeting of the Acbp gene was ob-
tained using a sequence replacement vector containing the loxP flanked
neomycin resistance cassette inserted in an XhoI site 400 bp 30 of exon
2 and a loxP recombination site inserted in the BamHI site 800 bp 50 of
exon 2. Heterozygous mice obtained from mating the chimeras with wild-
type C57BL/6N mice were mated with mice expressing Cre recombinase un-
der control of the EIIa promoter (EIIa-Cre mice) (Lakso et al., 1996). This re-
sulted in (1) mice carrying an Acbp allele with a loxP flanked exon 2, without
the neomycin resistance cassette (ACBP-flox), and (2) mice carrying an Acbp
allele with exon 2 replaced by a loxP sequence instead of the floxed exon 2
(ACBP-lox) (Figures S1A–S1D). Both the ACBP-flox and ACBP-lox strains
were backcrossed to the C57BL/6J Bom Tac strain for ten generations to
obtain a congenic background. ACBP-lox mice were mated with Alb-Cre
(Postic et al., 1999) and K14-Cre (Hafner et al., 2004) mice, respectively.
These ACBP-lox mice expressing either Alb-Cre or K14-Cre recombinase1410 Cell Reports 5, 1403–1412, December 12, 2013 ª2013 The Autwere then crossed with ACBP-flox mice to generate heterozygous ACBP
(ACBP-flox/ACBP-lox) mice with tissue-specific Cre recombinase activity in
the liver and skin, respectively (Figure S1E). Mice with hepatocyte- and ker-
atinocyte-specific depletion of ACBP are heterozygous for ACBP expression
(ACBP-flox/ACBP-lox) in tissues that do not express Cre recombinase.
Therefore, heterozygous ACBP-flox/ACBP-lox mice were used as controls
for mice with tissue-specific depletion of ACBP. The mice were housed un-
der standard conditions as described elsewhere (Neess et al., 2011), unless
otherwise stated. The animal experiments and breeding of transgenic mice
were approved by the Danish Animal Experiment Inspectorate. Pups were
housed with their mother and littermates until 21 days of age, at which
time they were removed from their mother and housed with littermates.
Pups that were sacrificed at day 21 were removed from their mother imme-
diately before they were euthanized. The mice were sacrificed between 8 and
11 a.m. Besides the normal chow diet supplied in the cage lid throughout the
period, the mice were provided soaked chow diet and water in the bottom of
the cage from the age of 10 days. For the experiment in which the mothers
were swapped, the ACBP/ mothers were transferred to ACBP+/+ pups and
the ACBP+/+ mothers were transferred to ACBP/ pups, when the pups
were 3 days old. For the artificial-barrier experiments, Vaseline was applied
to the whole body (excluding the head) of the pups twice a day from age
7 days to 21 days, and latex was applied in a similar way on days 7 and
14. For sampling of tissues, mice were euthanized by cervical dislocation.
Tissues were dissected and processed according to previously described
procedures (Neess et al., 2011).
Real-Time PCR
Levels of mRNA expression were determined by real-time PCR, and TFIIB
expression was used for normalization. The following real-time primers were
used: Acbp fwd: 50-TTTCGGCATCCGTATCACCT, Acbp rev: 50-TTTGTCA
AATTCAGCCTGAGACA; Acss2 fwd: 50-GCTTCTTTCCCATTCTTCGGT,
Acss2 rev: 50-CCCGGACTCATTCAGGATTG; Fasn fwd: 50- ATTGGTGGTGTG
GACATGGTC, Fasn rev: 50- CCCAGCCTTCCATCTCCTG; Hmgcr fwd: 50-
ACGCTCTTGTGGAATGCCTT, Hmgcr rev: 50-GGACGCCTGACATGGTGC;
Sqle fwd: 50-TGAACAAACGAGGCGTCCTT, Sqle rev: 50-GGTGCCTCAGGTT
ATACGCATC; Lss fwd: 50-TTATGGTGGTCCGCTCTTCC, Lss rev: 50-ATGTGA
CAGGTAATCAGGAGACCTG; TfIIb fwd: 50-GTTCTGCTCCAACCTTTGCCT,
TfIIb rev 50-TGTGTAGCTGCCATCTGCACTT.
Western Blotting and Immunohistochemistry
Proteins were extracted and analyzed essentially as previously described
(Neess et al., 2011). The primary antibodies used were rabbit anti-mouse
ACBP antiserum, rabbit anti-human TFIIB C-18 (1:1,000, sc-225; Santa
Cruz Biotechnology), rabbit anti-human HSL (1:500, 4107; Cell Signaling
Technology), rabbit anti-human phospho-HSL (Ser563, 1:500, 4139; Cell
Signaling Technology). The secondary antibody was horseradish peroxi-
dase-conjugated swine anti-rabbit IgG (1:1,000; Dako). Levels of pHSL
and HSL in WAT samples were quantified using ImageJ software (ImageJ
1.45).
ACBP immunostainingwas carried out as previously described (Neess et al.,
2011).
Quantification of CE and TAG
Total lipids were extracted from 30 mg of liver tissue by a modified Bligh and
Dyer method (Neess et al., 2011) and dissolved in butylated hydroxy toluene
(50 mg/l) in chloroform/methanol 1:1.
Equal amounts of lipid extracts, including standards, were sprayed onto
silica plates (high-performance thin-layer chromatography; Merck) and left
to air dry for 15 min. The plates were developed in a horizontal develop-
ment chamber with a solvent mixture of hexane/diethyl ether/acetic acid
(v/v/v; 80:30:1) for separation of neutral lipids and dried. Total CE was
determined by development with FeCl3$6H2O (0.5 mg/ml) in 5% H2SO4
and 5% CH3COOH in H2O, and burned at 110
C. Total TAG was deter-
mined by development with 10% CuSO4 (w/v) in 8% H3PO4 dissolved in
H2O and burned at 180
C. ImageJ software (ImageJ 1.45) was used for
quantification.hors
TEWL
Hair was removed from the abdominal skin of adult ACBP/, ACBP+/+, K14-
ACBP/, and heterozygous control male mice by electrical shaving followed
by 150 s treatment with Veet hair removal cream.
Five days after hair removal, the mice were anesthetized by inhalation of iso-
flurane and measurements of TEWL were carried out as described elsewhere
(Bloksgaard et al., 2012).
Lipolysis
Inguinal WAT from ACBP/ and ACBP+/+ mice was isolated, weighed, and
immediately submerged in Krebs-Ringer buffer containing 1% BSA. The sam-
ples were incubated in a water bath at 37C for 30 min. The tissue was then
removed and the glycerol content of the Krebs-Ringer buffer was determined
using the ZenBio (SGA1) colorimetric kit according to the manufacturer’s in-
structions. The amount of glycerol released was normalized to the initial wet
weight of the tissue.
Statistical Analyses
For the gene-expression data shown in Figures 1D, 2B, 2C, 3E, 4B, and 4D, an
unpaired parametric Student’s t test (GraphPad Prism 5) was used to compare
gene-expression levels between two genotypes (i.e., ACBP/ versus
ACBP+/+, heterozygous control versus Alb-ACBP/, and heterozygous con-
trol versus K14-ACBP/). Data are presented as mean value ± SEM. The sta-
tistical significance level was set at p < 0.05 and the numbers in gray indicate
the fold change between the two groups in case of significant difference. For
CE and TAG quantifications (Figures 5A and 5B), comparisons between two
genotypes (i.e., ACBP/ versus ACBP+/+) were carried out as described
above for gene-expression data (* indicates significant difference). Compari-
sons between control and Alb-ACBP/ or K14-ACBP/ mice in CE and
TAG quantifications, respectively, were performed using a one-way ANOVA
(GraphPad Prism 5). The statistical significance level was set at p < 0.05,
and with two pairwise comparisons, this resulted in a significant difference
when p < 0.025 (* indicates significant difference). For TEWL (Figures 3C
and 3D) lipolysis (Figure 6A) and quantification of western blots (Figure 6B),
comparisons between two genotypes (i.e., ACBP/ versus ACBP+/+, and
control versus Alb-ACBP//K14-ACBP/) were carried out as described
above for gene-expression data (* indicates significant difference).
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